Lemtrada hasn’t proven to help against disability in the treatment of relapsing multiple sclerosis, said U.S. advisers who questioned whether the company’s studies were conducted well enough to assess the drug.
While the U.S. Food and Drug Administration advisory panel decided that potential safety risks don’t preclude approval of Lemtrada, its members voted 14-2 that the drug didn’t help improve a patient’s disability. The agency isn’t required to accept the recommendations of its advisers..... Read More - http://www.ms-uk.org/lemtrada
MS drug Lemtrada does not benefit patients, FDA panel says
MS drug Lemtrada does not benefit patients, FDA panel says
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1035 Views
-
Last post by NHE
-
- 0 Replies
- 1112 Views
-
Last post by ElliotB
-
- 0 Replies
- 1724 Views
-
Last post by CureIous
-
- 0 Replies
- 1540 Views
-
Last post by frodo
-
- 0 Replies
- 1537 Views
-
Last post by NHE
-
- 0 Replies
- 493 Views
-
Last post by NHE
-
- 0 Replies
- 1668 Views
-
Last post by NHE
-
- 1 Replies
- 3139 Views
-
Last post by Tif
-
- 0 Replies
- 2442 Views
-
Last post by frodo